Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › rasagiline

rasagiline

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of rasagiline

13 trials tracked of rasagiline: 5 in phase 3 or 4.

13Trials tracked
5Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 3 Phase 3 2 Phase 2 5 Phase 1 2 Other / NA 1
  1. Phase 4 Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease Completed
  2. Phase 4 Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease Completed
  3. Phase 4 Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease Completed
  4. Phase 3 Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China Completed
  5. Phase 3 A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease Completed
  6. Phase 2 Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) Completed
Show 7 more trials
  1. Phase 2 Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) Completed
  2. Phase 2 Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) Completed
  3. Phase 2 Rasagiline Rescue in Alzheimer's Disease Clinical Trial Completed
  4. Phase 2 Image Parkinson's Disease Progression Study Completed
  5. Phase 1 Effect of Rasagiline on BIA 9-1067 Pharmacokinetics Completed
  6. Phase 1 Effect of BIA 9-1067 on Rasagiline Pharmacokinetics Completed
  7. N/A Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety" Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Rasagiline and selegiline show comparable efficacy and safety in early Parkinson's disease
Neurology Meta-analysis
Rasagiline and selegiline show comparable efficacy and safety in early Parkinson's disease Rasagiline and selegiline offer similar relief for early Parkinson's
This meta-analysis indirectly compared rasagiline with selegiline in early Parkinson's disease, finding no statistically significant differe…
Two common medications for early Parkinson's disease provide similar symptom relief, but one option may be more expensive than the other.
Aug 20, 2026
Safinamide 100 mg outperforms rasagiline 1 mg and zonisamide 25 mg for motor fluctuations
Neurology Sys. Review
Safinamide 100 mg outperforms rasagiline 1 mg and zonisamide 25 mg for motor fluctuations Safinamide beats rasagiline for Parkinson's motor symptoms
This network meta-analysis of randomized controlled trials evaluated various adjunct therapies for Asian Parkinson's disease patients with m…
For Asian Parkinson's patients, adding safinamide to levodopa reduces OFF-time more than rasagiline or zonisamide.
Jun 16, 2026
Fatal serotonin syndrome in Parkinson's patient on rasagiline after sequential SSRI administration
Psychiatry
Fatal serotonin syndrome in Parkinson's patient on rasagiline after sequential SSRI administration Case report describes fatal serotonin syndrome in older Parkinson's patient on multiple medications
A case report describes a 72-year-old Parkinson's patient on rasagiline who developed fatal serotonin syndrome after sequential sertraline a…
A 72-year-old Parkinson's patient died after taking two antidepressants with a genetic makeup that slowed drug processing, causing fatal ser…
Frontiers Apr 1, 2026